Travere Therapeutics

Unlock to Claim this listing

Add / Modify Company

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, as well as for adjunctive treatment of patients with peroxisomal disorders; and Thiola and Thiola EC, a tiopronin tablet for the treatment of homozygous cystinuria. The company’s product candidates also consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy; and TVT-058, a novel investigational human enzyme replacement candidate, which is in Phase I/II clinical trials for the treatment of classical homocystinuria.

Click to rate this company
[Total: 0 Average: 0]

3.11

Overall Excellence Rating

Industry

Pharmaceuticals & Biotechnology

Category

Biotechnology

ESG/Ethical Impact

Travere Therapeutics Inc. is committed to reducing its environmental footprint. Through initiatives like waste reduction, energy efficiency improvements, and responsible supply chain practices, the company strives to minimize its environmental impact. Travere Therapeutics Inc. places a strong emphasis on social responsibility. The company actively supports community engagement and development, fostering partnerships that promote health and education, and contributing to local economies where it operates. Strong governance and ethical practices are integral to Travere Therapeutics Inc.’s operations. The company upholds high standards of transparency, accountability, and fairness in its decision-making processes, ensuring the trust of its stakeholders. Travere Therapeutics Inc.’s ESG efforts are closely aligned with its financial sustainability. By embracing responsible business practices and managing potential risks, the company aims to safeguard its long-term financial performance and create value for shareholders. Demonstrating an unwavering commitment to ethics and integrity, Travere Therapeutics Inc. places a strong emphasis on responsible business practices. By adhering to codes of conduct that promote honesty, fairness, and accountability, the company cultivates an environment of mutual respect and trust.

Eligible Awards

Coming Soon





Claim Your Award Badges

Do you work with Us

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received

2023

Revenues

235000000

Website Traffic

Employee Rating

4.2

Customer Rating

Company Size

100-1000

ESG Risk Rating

3

We’re Happy to Help.

Do you have questions about your ranking, our projects, or why you’re not on the list?
Scroll to Top

You need to be registered to claim or modify your listings

Excellence In My Industry

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business in your specific industry – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best Practice Certified

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best of Best Practices

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the top 20 companies in your industry that has met the criteria for our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Newsweek Excellence 1000

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the Top 1000 companies that demonstrate excellence across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.